Wan, P.; Sun, J.G.; Hao, G.; Zhang, X.X.; Xiao, D.W.; Liu, Z.H. Determination of rhein in plasma, urine and feces by HPLC-fluorescence detection and its pharmacokinetics in healthy volunteers. J. China Pharm. Univ., 2013, 44, 73-76.
Proter, S.P.A. Anthraquinone derivatives for the treatment of arthritis, IT1098332B1985.
Friedmann, CA Anthraquinone derivatives for the treatment of arthritis, FR2508798B11986.
Dall’asta, L; Coppi, G; Scevola, M.E. Diacetylrhein potassium salt and its therapeutical use in the treatment of arthritis, EP0243968B11991.
Cong, X.D.; Zhang, Y.; Dai, D.Z.; Dai, Y.; Chen, G.X. Application of complexes of rhein or rhein compounds in preparation of medicine for treating osteoarthritis, CN1899275B2013.
Cong, X.D.; Zhang, Y.; Dai, D.Z.; Dai, Y.; Chen, G.X. Application of complexes of rhein or rhein compounds in preparation of medicine for treating diabetic nephropathy, CN1899277B2013.
Cong, X.D.; Zhang, Y.; Dai, D.Z.; Dai, Y.; Chen, G.X. Application of complexes of rhein or rhein compounds in preparation of medicine for recovery of gastrointestinal function and prevention of intestinal adhesion, CN1899276B2014.
Cong, X.D.; Dai, D.Z.; Zhang, Y.; Dai, Y. Application of complexes of rhein or rhein compounds and arginine in preparing medicine for treating diabetic vascular complications, CN103202829A2013.
Cong, X.D.; Dai, D.Z.; Zhang, Y.; Dai, Y. Application of complexes of rhein or rhein compound and arginine in preparing medicine for treating diabetic vascular complications, CN103169690A2013.
Liu, D.H.; Zhao, Z.Y. A Chinese medicle powder injection for treating arthritis and its preparation method, CN1712041A2005.
Charbit, S.; Schutze, F.; Provvedini, D.; Ficheux, H. Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase, US20060058392A12006.
Brown, C.O., III; Chen, Z.G.; Li, J.Y.; Lu, W.S. Diacerein or its analogs for inhibiting the expression of ASC, the expression of NLRP3 and/or the formation of NLRP3 inflammatory complexes, CN108349867A, 2018.
Pietrangelo, A; Travagli, V Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same, EP1718679B12007.
Carlino, S.; Napoli, A.D. Dioxoanthracene sulphonate derivatives, EP2220036B12012.
Rosini, S; Mian, M. 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities, US5362750A1994.
Rosini, S.; Mian, M. Acylamino-alkyliden-hydroxy-bisphosphonic acids esters and salts thereof, wherein the acyl group is derived from an acid having antiinflammatory activity, US5466682A1995.
Rosini, S.; Mian, M. Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment, US5451606A1995.
Rosini, S; Mian, M. Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity, US5330981A, 1994.
Cifter, U.; Turkyilmaz, A. AKALIN N.P.; ZENGINER, S.; Mutlu, O. Combinations of diacerein and non-steroidal inflammation drugs, EP2797584B12015.
Benetti, D; Aloisi, R; Guainai, G; Rosini, S. Mono- and disulfosubstituted anthraquinones and their use for the treatment of bone matrix disorders, US5856358A1999.
Napoli, G.D. Rhein derivatives and new processes for producing rhein derivatives, US5864048A1999.
Quirk, S. Matrix metalloproteinase inhibitors, US6600057B22003.
Bannister, R.M.; Baxter, A.D.; Cooper, N.; Brew, J. 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as modulators of IL-10 production for treatment of autoimmune or inflammatory conditions, GB2398779A2004.
Baxter, A.D.; Walmsley, A. Ester derivatives of rhein and their therapeutic use, US7728035B22010.
Li, J.C.; Huang, P.; Liu, Y.W. Rhein derivatives and their therapeutic use, CN102225913B2013.
Li, J.C.; Huang, P.; Niu, Q. Ether derivatives of rhein and their therapeutic use, CN102225896B2013.
Jiang, M.; Xu, X.; Qi, X.Y.; Yang, C.H.; Deng, L.F. A class of rhein compounds and their uses, CN105884645B2018.
Jiang, M.; Xu, X.; Deng, L.F.; Jiang, B.; Yang, C.H. Rhein thioamide compounds,their preparation and use, CN107298648B2019.
Li, L.Z.; Cui, Y.; Zhang, Y.L.; Cui, Y. Rhubarb anthraquinone derivatives, and their preparation and pharmaceutical compositions, CN100368426C2008.
Tang, L.; Wang, J.T.; Zhu, G.F. Bisphosphonate rhein ether derivatives with bone affinities and their preparation method, CN101735271A2010.
Ji, M.; Duan, Y.B.; Yu, J. Synthesis method and application of bone-targeted anti-inflammatory drugs, CN101475484B2012.
Xie, H.B.; Gu, S.H.; Lv, W.H.; Li, Q.Y.; Hu, H.F. Rhein derivatives and their application, CN104926754A2015.
Xie, H.B.; Gu, S.H.; Lv, W.H.; Li, Q.Y. A carboxylic ester derivative of rhein and its application, CN104945269A2015.
Chen, L.J.; Li, Y.; Wang, X.; Jia, D.C.; Cui, Q.G. Rhein ester derivatives and their preparation and application, CN106631808A2017.
Gallagher, P.T.; Owton, W.M.; Williams, A.C. Pharmaceutical compounds, US5792797A1998.
Yang, C.H.; Miu, Z.H.; Yue, Z.Z.; Liang, Y.K.; Feng, J.M.; Li, J.X; He, Q. Anthraquinone and thiazole compound, preparation method and application thereof, CN104250246B2017.
Wang, H.S.; Huang, R.Z.; Pan, Y.M.; Yao, G.Y.; Dai, W.L.; Ye, M.Y; Chen, Z.F Rhein aminophosphonate derivatives,and their synthesis method and application, CN103524555B2016.
Wang, H.S.; Huang, R.Z.; Pan, Y.M.; Yao, G.Y.; Dai, W.L.; Ye, M.Y; Chen, Z.F. Diacerein aminophosphonate derivatives,and their synthesis method and application, CN103524556B2016.
He, L.Q.; Huang, J.K. Rhein aminol ester derivatives,their preparation and medical use, CN103709052B2016.
Huang, J.K.; He, L.Q.; Huang, P.; Bai, Z.W.; Zhang, W.W. Synthesis of rhein aminol ester derivatives and their anti-osteosarcoma cell activity. Acta Pharm., 2018, 53, 249-255.
Lin, Y.J.; Zhen, Y.S.; Liu, X.J.; Wu, S.Y.; Xu, X.D. Preparation process of lysine rhein and its application in tumor therapy, CN101255121B2012.
Lin, Y.J. Preparation of lysine rhein and its anti-tumor mechanism. Ph.D; Peking Union Medical College, 2008.
Xu, W.Q.; Li, J.Y.; Zhu, Z.H.; Li, G.Q.; Shen, X.; Zhang, Y.J. Rhein derivatives,their synthesis method and use, CN103864642B2016.
Xie, J.W.; Zhou, C.J.; Dai, B.; Zhang, J.; Liu, P. A rhein compound and its preparation and application, CN104557603A2015.
Chen, H.S. Platinum salts of organic acids, preparation thereof and application in preparation of anticancer drugs, CN101289467A2008.
Ou, B.N.; Li, L.Q. Ester derivatives of rhein polyol and their use for preparing antitumor medicine, CN104529782A2015.
Liu, H.K.; Kong, Y.Q.; Qian, Y.; Su, Z.; Li, J.; Wu, J. Organic compounds modified by rhein-specific group, and their aryl metal complex, preparation method and application, CN108530343A2018.
Wang, B.H.; Dai, C.F.; Draganov, A.; Yang, X.C.; Sun, G.J.; Yang, C.H.; Chen, W.X.; Ni, N.T.; Zhou, M.X.; Gu, L.B. Anthraquinone analogs and methods of making and using thereof US20150203442A1, 2015.
Hou, H.X.; Tian, W.; Li, D.R. Preparation and application of an anthraquinone compound for inducing para-apoptosis of liver cancer cells, CN108586278A2018.
Li, L.S. Use of rhein or rhein salts in the preparation of medicine for treating diabetic nephropathy, CN1086289C2002.
Zhang, Y. Application of rhein or its salt in preparing medicine for treating chronic nephritis or chronic renal failure, CN101301284B2010.
Wang, C.P.; Sun, W.X.; Fang, Z.; Lu, C.L.; Zhu, Z.H.; Mao, L.Z.; Zhang, H.Y.; Zhu, M.H; Zhang, H.Y.; Zhu, M.H. Rhein and berberine ion pair compound, its preparation method and application, CN103319479B2015.
Gu, S.H.; Cao, H.; Sun, W.X. A rhein derivative and its preparation and use, CN102060809B2015.
Li, X.G.; Zhu, X.K.; Ye, X.L. 3-alkoxy-6-carboxyl rhein or pharmaceutically acceptable salt, and their preparation method and application, CN101613271B2013.
Zhang, F.Y.; Chen, Q.Y. Water-soluble choline salt of rhein and its derivatives, their preparation and application in medicine, CN103965062A2014.
López-Ibarra, D.M.T.; Cantín, N.M.I; Gaza, E.V.; Lao, I.S.; Cruz, S.V. Beta-amyloid-directed multitarget compounds for the treatment of alzheimer’s disease, US9238626B22016.
Liu, J.B. Esters of anthraquinone acid and kojic acid, and their application as tyrosinase inhibitors, CN108546259A2018.
Liu, J.B. Application of rhein and its vitamin C ester derivatives as tyrosinase inhibitors, CN108586400A2018.
Hua, X.; Liu, S.G.; Zhang, W.J. A medicine for preventing and treating haemophilus parasuis and its application, CN106955280A2017.
Yang, J.Q.; Zhao, S.X.; An, J.L.; Deng, L.; Lei, Y.Y. Rhein ester derivatives and their preparation method and application, CN109053798A2018.
Qin, Y.; Sheng, X.Y. Application of rhein in the prevention and treatment of fatty liver, CN101327204B2010.
Liu, L.P. Conjugated compounds of ursodeoxycholic acid with berberine or L-carnitine and their composition and method, CN108137575A2018.
Ju, X.W.; Hou, X.H.; Fan, G.P.; Bai, S.F.; Zhang, J.Z.; An, Q.; Chen, H. Synthesis and bone affinity of rhein-N-β-hydroxyethyl tegafurate. J. Chin. People’s Armed Police Acad., 2008, 375-377.
Wang, Z.M.; Chen, H.; Cao, B.; Wang, Y.; Mou, H.J. Study on the mechanism of action of rhodophyllotoxin ester on human osteosarcoma cells. Chin. Herb. Med., 2008, 67-71.
Xiang, H. Research on the structure and pharmacological action of rhein metal complex. Master; Chengdu University of Traditional Chinese Medicine, 2014.
Wang, X.D.; Li, L.; Han, Y.P. Synthesis and antibacterial activity of rhein derivatives. Forest Prod. Chem. Indust., 2018, 38, 105-111.